Strata Critical Medical (BLDE) has sold its Passenger division to Joby Aviation, with an initial payment in Joby stock and up to $35 million in additional payments based on employee retention and financial milestones. The company is now fully focused on medical air transportation, specializing in organ delivery for transplant. With a market cap of $386 million, Strata reports 4.2% annual revenue growth and 39.7% growth over three years. Valuation indicators suggest modest overvaluation, with analysts maintaining a price target of $7.75. Management sees this sale as a strategic move towards more stable growth. Friday, BLDE closed at $4.73.

Read more at Nasdaq.: Strata Critical Medical Sells Passenger Unit To Joby, Focuses On Healthcare Logistic